Use of CRP/albumin ratio in predicting severity of acute pancreatitis

Recruiting

• Conditions: Acute pancreatitis, unspecified,

• Registration Number: CTRI/2021/01/030806
• Lead Sponsor: Kasturba medical college Manipal

Brief Summary

It is a prospective observational study. Patients who will be diagnosed with acute pancreatitis and satisfying the criteria will be included. Standard data will be collected during patients admissions as a part of routine clinical practice. Data will be extracted from this data base. CRP/albumin ratio will be calculated and compared with other routine investigations that are routinely used in cases of pancreatitis (isolated CRP, hematocrit, Glasgow imrie score, BMI, CT severity) in assessing the severity and prognosis of the disease.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-31
• Last Update Posted: 2021-11-14

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

1. Patients diagnosed with acute pancreatitis.

Exclusion Criteria

1. Pregnancy 2) Patients with chronic liver disease 3) Recurrent/chronic pancreatitis.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reliability of CRP/albumin ratio in predicting the severity, morbidity and mortality in acute pancreatitis	10 days

Secondary Outcome Measures

Name	Time	Method
Efficacy of crp/albumin ratio in predicting prognosis of acute pancreatitis compared to routinely used other investigations	10 days

Trial Locations

Locations (1)

Kasturba hospital; 🇮🇳 Udupi, KARNATAKA, India

Kasturba hospital

🇮🇳Udupi, KARNATAKA, India

Dr R Jayanth

Principal investigator

9492177086

jayanth.r2@learner.manipal.edu